Company / Total Assets
CANNAPHARMARX, INC. Total Assets History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$7.0M
FY2025
5-year range
$114.3K / $10.8M
FY2021-FY2025
Trend
-35.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 10 years, ranging from $0 in FY2017 to $16M in FY2019.
Based on SEC 10-K filings.
$7M in FY2025 with a 10-year CAGR of +89.0%.
Improved from $5M to $7M over the past 3 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +9.0%
- 5-Year CAGR
- -4.3%
- 10-Year CAGR
- +89.0%
Key checks
Key Insights
- 5-year CAGR of -4.3%, indicating a declining trend.
- In FY2025, total assets decreased 35.2% year-over-year.
- Peak total assets was recorded in FY2019.
- Lowest total assets in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -18.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.0M | -35.2% |
| FY2024 | $10.8M | +100.1% |
| FY2022 | $5.4M | +4635.6% |
| FY2021 | $114.3K | -98.7% |
| FY2020 | $8.7M | -45.4% |
| FY2019 | $16.0M | +58.6% |
| FY2018 | $10.1M | - |
| FY2017 | $0 | -100.0% |
| FY2016 | $1.7K | -86.2% |
| FY2015 | $12.1K | -99.3% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026